PALB2 and breast cancer: Susceptibility genes with high or moderate penetrance (i.e., BRCA1, BRCA2, PALB2, ATM, and CHEK2) have been identified in 30 to 40% of patients with a family history of breast cancer, but only in 5% of sporadic breast cancer cases.